Zou et al. generated a CD133-specific CAR T-cell with IKZF3-knockout that demonstrated superior killing of glioma cells in vitro, as well as increased IFN-γ, IL-2, TNF-α, and GM-CSF cytokine levels compared to their unmodified counterparts [105] (Table 5). This evidence concerns the gene TNF and central nervous system cancer.